MEI Leadership


 
Richard Schmidt, Chief Executive Officer, President, Board Member

Richard C. Schmidt, MS

Chief Executive Officer, President, Board Member

Mr. Schmidt began working with MEI in 2011 and became the Chief Executive Officer in January, 2012. Mr. Schmidt has extensive leadership and business experience in all aspects of development and commercialization of complex medical devices.

Before joining MEI, Mr. Schmidt was with Accuray (formerly TomoTherapy) for 11 years, starting as Tomotherapy’s first mechanical engineer. While at Accuray, Mr. Schmidt also served as Hardware Engineering Manager, Strategic Programs Manager and Senior Technologist. He hired, developed, led and mentored the hardware engineering teams that designed and commercialized the TomoTherapy Hi-ART system. The TomoTherapy system received FDA 510(k) approval and is now operational at over 500 cancer treatment facilities around the world, providing millions of cancer treatment fractions per year.

Mr. Schmidt has an undergraduate degree in Physics and a graduate degree in Mechanical Engineering. He has published papers in Nuclear Physics, Accelerator Physics, Medical Physics and a thesis on Free-Piston Engine Development. He is a co-inventor on patents for x-ray detectors and x-ray targets and has several patents pending.

 
 
 
Clinical Officer, Founder, Inventor, Board Member


 

David M. Mahvi, MD

Vice President, Founder, Inventor, Board Member

Dr. David Mahvi is the James R. Hines Professor of Surgery and Chief of Gastrointestinal and Oncologic Surgery at Northwestern University Feinberg School of Medicine. Prior to this he was Professor and Chief of Surgical Oncology at the University of Wisconsin’s Department of Surgery. Dr. Mahvi completed his undergraduate work in Microbiology and Pre-medicine at the University of Oklahoma and went on to obtain his MD at the Medical University of South Carolina. He then served his residency and completed a research fellowship in Immunology at Duke University Medical Center in Durham, North Carolina.

Dr. Mahvi’s research interests focus on the development of new biomedical devices in the treatment of liver cancer. He currently has five patents and is in the process of bringing several devices to the market. He is a national and international authority in the field of hepatobiliary cancer.

Dr. Mahvi has authored or co-authored over 100 peer reviewed research articles and has presented both nationally and internationally on topics related to cancer. He currently serves as an editorial board member of the Annals of Surgery, The Journal of Gastrointestinal Surgery and Hepatobiliary Surgery. He is Chair of the Board of Trustees of The Society for Surgery of the Alimentary Tract (SSAT) and is a Director of the American Board of Surgery.

 
 
 
Biomedical and Software Engineer, Founder, Inventor, Chairman of the Board


 

Dr. Dieter Haemmerich, Ph.D.

Biomedical and Software Engineer, Founder, Inventor, Chairman of the Board

Dr. Haemmerich is Associate Professor in the Department of Pediatrics at the Medical University of South Carolina, and Adjunct Faculty of Bioengineering at Clemson University. He completed degrees in Electrical and Computer Engineering (Vienna University of Technology, Austria), and Biomedical Engineering (University of Wisconsin-Madison).

Dr. Haemmerich’s research interest is in development of novel medical devices for treatment of cancer and cardiac arrhythmias. This includes surgical devices as well as devices for heat-based treatment of diseases. He is internationally renowned for development of heat-based therapy approaches, is a Fellow of the Heart Rhythm Society, and currently serves as President-elect of the Society of Thermal Medicine.

Dr. Haemmerich has authored or co-authored about 70 peer reviewed research articles, is on the editorial board of several scientific journals including Critical Reviews of Biomedical Engineering, and chairs the IEEE committee on Therapeutic Systems and Technologies.

In a prior business venture, in 1997 Dr. Haemmerich founded a software company that developed a music management system (similar to iTunes released 3 years later) specialized for dancing schools. The software rights were sold to another company in 1999, and software is still available today.

 
 
 
Biomedical Scientist, General Manager, Founder, Inventor, Board Member


 

Dr. James A. Will, DVM, Ph.D.

Biomedical Scientist, Treasurer, Secretary, Founder, Inventor, Board Member

Dr. Will is an Emeritus professor from the University of Wisconsin, Madison. His long career has been focused on comparative medicine mainly in the cardiopulmonary field with more than 125 refereed publications, several book chapters and he was the principal editor of “The Pulmonary Circulation in Health and Disease.

His University positions have included an Assistant Professorship in the Department of Medicine, Adjunct Professor of Anesthesiology, Emeritus Professor of Surgery, Medical School as well as Professor of Animal Health and Biomedical Sciences (AHABS) and Emeritus Professor of Pathobiology in the School of Veterinary Medicine and Emeritus Professor of Animal Sciences, College of Agricultural and Life Sciences. His administrative experience included Chair of Veterinary Sciences, Director for the Graduate School of the Research Animal Resources Center, Chair of the Biological Sciences Divisional Committee and various other responsibilities. He is now the science editor for the Faculty of Medicine, Khon Kaen University, Thailand for all publications from the basic and clinical sciences.

He was a consultant to Janssen Pharmaceuticals, Beersa, Belgium, a division of J&J, and its chairman, Dr. Paul Janssen for more than 10 years. This was followed by a consultancy with The Upjohn Company and its chairman, Dr. Ted Cooper, Former Surgeon General for more than 5 years. In addition he has served on review panels for the Congressionally Mandated Military Medical Research Program.

 
 
 
john-webster, Founder, Inventor


 

John G. Webster, Ph.D.

Founder, Inventor

Dr. Webster received the B.E.E. degree from Cornell University, Ithaca, NY, USA in 1953, and the M.S.E.E. and Ph.D. degrees from the University of Rochester, Rochester, NY, USA in 1965 and 1967, respectively.

Dr. Webster is Professor Emeritus of Biomedical Engineering at the University of Wisconsin-Madison, USA. In the field of medical instrumentation he teaches undergraduate and graduate courses in bioinstrumentation and design. He does research on improving electrodes for ablating liver to cure cancer, on safety of electro-muscular incapacitating devices, on a miniature hot flash recorder, and on an implantable intracranial pressure sensor.

Dr. Webster is the editor of the most-used text in biomedical engineering: Medical instrumentation: application and design, Fourth Edition New York, John Wiley & Sons, 2009, and has developed 22 other books including the Encyclopedia of medical devices and instrumentation, Second Edition, New York: John Wiley & Sons, 2006, and 200 research papers.

Dr. Webster is a fellow of the Institute of Electrical and Electronics Engineers (IEEE), Instrument Society of America, American Institute of Medical and Biological Engineering, and Institute of Physics. He has been a member of the IEEE-EMBS Administrative Committee and the NIH Surgery and Bioengineering Study Section. He is the recipient of the 2001 IEEE-EMBS Career Achievement Award.

 
 
 
Board Member


 

Mr. Paul J. Reckwerdt

Board Member

Mr. Reckwerdt has been working for the past twenty five years in medical related product development and research. He founded and drove the growth of TomoTherapy Incorporated, a company selling a novel system for advanced cancer treatments. Besides being one of the originators and inventors of the TomoTherapy concept, he founded and guided the company through five successful rounds of investments, a very successful IPO with a market cap of $1.2 billion and the global launch of the Hi-ART system. Starting with seven people in 1999 he built the global infrastructure of the company to over 700 employees and installations in twenty-six countries around the world. Retiring in 2009 he currently is active in other scientific product development and relief work in the third world.

Mr. Reckwerdt’s early research at the University of Wisconsin included implementation and analysis of clinical studies into Parkinson disease, ALS, dementia, and epilepsy. Later research in cancer therapy has lead into his entrepreneurial life and TomoTherapy.

He currently holds over twenty U.S. patents and sits on the advisory board of the UW Madison Weinert Center for Entrepreneurship, for which he speaks and mentors students, and is starting his fourth company.

The author or co-author of over 25 peer reviewed papers and presentations, Mr. Reckwerdt is also the recipient of the Farrington Daniels Award in Medical Physics and the Ernst and Young Entrepreneur of the Year award.